Replies to post #31809 on OncoSec Medical Inc (ONCSQ)

[TomP1]

This is what I said:

The combotrial is a p2b and not a p3, hence the population is a lot smaller but still designed to be statistically significant.

p2b is statistically significant, that has been said on multiple presentations. And as the p2b is an open label, there will be interim data release. Thas has also been said on multiple presentations.

To pre-empt your next question: go back, listen to the presentations, and you will hear it.